Literature DB >> 11483479

Use of sertraline, paroxetine and fluvoxamine by nursing women.

V Hendrick1, A Fukuchi, L Altshuler, M Widawski, A Wertheimer, M V Brunhuber.   

Abstract

BACKGROUND: The pharmacological treatment of depression in nursing women requires information on the magnitude of medication exposure to the infant that may occur through breast milk. AIMS: To examine serum concentrations of antidepressants in infants exposed to these medications through breast-feeding.
METHOD: Maternal and infant serum concentrations of sertraline, paroxetine and fluvoxamine were determined with high-performance liquid chromatography (limit of detection=1 ng/ml).
RESULTS: No detectable medication was present in any infant exposed to paroxetine (n=16) or fluvoxamine (n=4). Among infants exposed to sertraline (n=30), detectable medication was present in 24% of serum samples. A significant negative correlation was found between infant age and infant serum concentration. Sertraline was significantly more likely to be detected in an infant if the mother's daily dose was 100 mg or higher. No adverse sequelae occurred in any infant.
CONCLUSIONS: This study shows that paroxetine, fluvoxamine and sertraline produce minimal exposure to infants when taken by nursing mothers.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11483479     DOI: 10.1192/bjp.179.2.163

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


  14 in total

Review 1.  Etiology and treatment of postpartum depression.

Authors:  Deborah Lynne Flores; Victoria C Hendrick
Journal:  Curr Psychiatry Rep       Date:  2002-12       Impact factor: 5.285

2.  Treatment of postnatal depression.

Authors:  Victoria Hendrick
Journal:  BMJ       Date:  2003-11-01

Review 3.  Neonatal exposure to drugs in breast milk.

Authors:  Patrick J McNamara; Maggie Abbassi
Journal:  Pharm Res       Date:  2004-04       Impact factor: 4.200

Review 4.  Use of contemporary antidepressants during breastfeeding: a proposal for a specific safety index.

Authors:  Salvatore Gentile
Journal:  Drug Saf       Date:  2007       Impact factor: 5.606

Review 5.  Sertraline and breastfeeding: review and meta-analysis.

Authors:  Emily Pinheiro; Debra L Bogen; Denada Hoxha; Jody D Ciolino; Katherine L Wisner
Journal:  Arch Womens Ment Health       Date:  2015-01-15       Impact factor: 3.633

6.  ABM Clinical Protocol #18: Use of Antidepressants in Breastfeeding Mothers.

Authors:  Natasha K Sriraman; Kathryn Melvin; Samantha Meltzer-Brody
Journal:  Breastfeed Med       Date:  2015 Jul-Aug       Impact factor: 1.817

Review 7.  Breastfeeding and antidepressants.

Authors:  Tiffany Field
Journal:  Infant Behav Dev       Date:  2008-02-12

Review 8.  Luteal phase administration of agents for the treatment of premenstrual dysphoric disorder.

Authors:  Ellen W Freeman
Journal:  CNS Drugs       Date:  2004       Impact factor: 5.749

9.  Pharmacokinetics of duloxetine in breast milk and plasma of healthy postpartum women.

Authors:  Evelyn D Lobo; Corina Loghin; Mary Pat Knadler; Tonya Quinlan; Lu Zhang; Jill Chappell; Richard Lucas; Richard F Bergstrom
Journal:  Clin Pharmacokinet       Date:  2008       Impact factor: 6.447

Review 10.  Use of psychotropic medications in treating mood disorders during lactation : practical recommendations.

Authors:  Malin Eberhard-Gran; Anne Eskild; Stein Opjordsmoen
Journal:  CNS Drugs       Date:  2006       Impact factor: 5.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.